Cooperation SeekingCreative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop our ADCC/CDC-enhanced antibodies or immutoxins. For commercial partners interested in our therapeutic biobetter product, Creative Biolabs welcomes collaboration.
Chemically, it is a fusion protein consisting of the antigen-binding fragment (Fab) of a monoclonal antibody and the superantigen Staphylococcus enterotoxin A (SEA / E-120, "estrogen"). Fab binds to antigen 5T4 expressed by various tumor cells, and superantigen induces immune response by activating T lymphocytes.
Non-small cell lung carcinoma
All products and services are for Research Use Only. Do Not use in humans.
Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.